Pharmaceuticals

Wall Street experienced significant declines, with major indices dropping over 1.5% due to economic slowdown fears and inflation concerns. Viking Therapeutics Inc. (NASDAQ:VKTX) defied market trends, rising 7.71% amid rumors of a potential acquisition by Pfizer Inc. Despite reporting increased quarterly net